1. Home
  2. RXST vs DGICB Comparison

RXST vs DGICB Comparison

Compare RXST & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXST
  • DGICB
  • Stock Information
  • Founded
  • RXST 1997
  • DGICB 1986
  • Country
  • RXST United States
  • DGICB United States
  • Employees
  • RXST N/A
  • DGICB N/A
  • Industry
  • RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DGICB Property-Casualty Insurers
  • Sector
  • RXST Health Care
  • DGICB Finance
  • Exchange
  • RXST Nasdaq
  • DGICB Nasdaq
  • Market Cap
  • RXST 631.1M
  • DGICB 605.9M
  • IPO Year
  • RXST 2021
  • DGICB N/A
  • Fundamental
  • Price
  • RXST $13.61
  • DGICB $19.40
  • Analyst Decision
  • RXST Buy
  • DGICB
  • Analyst Count
  • RXST 10
  • DGICB 0
  • Target Price
  • RXST $39.30
  • DGICB N/A
  • AVG Volume (30 Days)
  • RXST 661.3K
  • DGICB 2.9K
  • Earning Date
  • RXST 08-04-2025
  • DGICB 07-24-2025
  • Dividend Yield
  • RXST N/A
  • DGICB 3.40%
  • EPS Growth
  • RXST N/A
  • DGICB 1206.68
  • EPS
  • RXST N/A
  • DGICB 2.03
  • Revenue
  • RXST $148,310,000.00
  • DGICB $993,637,805.00
  • Revenue This Year
  • RXST $22.16
  • DGICB $3.27
  • Revenue Next Year
  • RXST $20.91
  • DGICB $4.01
  • P/E Ratio
  • RXST N/A
  • DGICB $9.84
  • Revenue Growth
  • RXST 46.70
  • DGICB 5.29
  • 52 Week Low
  • RXST $12.53
  • DGICB $10.75
  • 52 Week High
  • RXST $60.81
  • DGICB $20.46
  • Technical
  • Relative Strength Index (RSI)
  • RXST 38.20
  • DGICB 67.35
  • Support Level
  • RXST $13.41
  • DGICB $17.00
  • Resistance Level
  • RXST $14.88
  • DGICB $17.98
  • Average True Range (ATR)
  • RXST 0.73
  • DGICB 0.42
  • MACD
  • RXST -0.14
  • DGICB 0.02
  • Stochastic Oscillator
  • RXST 6.78
  • DGICB 77.78

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

About DGICB Donegal Group Inc. Class B

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

Share on Social Networks: